Skip to main content
. 2019 Jun 7;10(3):157–164. doi: 10.14740/cr870

Table 1. Patient Characteristics According to Pre-Transplant ICU Stay (N = 19,508).

Characteristic Missing data
Not in ICU (N = 13,199)
In ICU (N = 6,309)
P value
N N (%) N (%)
Age group (years) 0 < 0.001
  < 1 384 (3%) 841 (13%)
  2 - 11 559 (4%) 408 (6%)
  12 - 18 520 (4%) 349 (6%)
  19 - 29 746 (6%) 434 (7%)
  30 - 39 988 (7%) 429 (7%)
  40 - 49 1,865 (14%) 765 (12%)
  50 - 59 3,792 (29%) 1,468 (23%)
  60 - 69 3,996 (30%) 1,468 (23%)
  ≥ 70 349 (3%) 147 (2%)
Female gender 0 3,573 (27%) 1,944 (31%) < 0.001
Race 0 < 0.001
  Non-Hispanic White 8,928 (68%) 4,028 (64%)
  Non-Hispanic Black 2,597 (20%) 1,278 (20%)
  Hispanic 1,105 (8%) 677 (11%)
  Other 569 (4%) 326 (5%)
Body mass index category 13 < 0.001
  Underweight 508 (4%) 521 (8%)
  Normal weight 4,526 (34%) 2,716 (43%)
  Overweight 8,160 (62%) 3,064 (49%)
Indication for transplant 0 < 0.001
  Congenital heart disease 932 (7%) 870 (14%)
  Hypertrophic cardiomyopathy 298 (2%) 146 (2%)
  Ischemic cardiomyopathy 4,767 (36%) 1,759 (28%)
  Non-ischemic cardiomyopathy 6,198 (47%) 3,065 (49%)
  Restrictive cardiomyopathy 432 (3%) 207 (3%)
  Valvular heart disease 190 (1%) 113 (2%)
  Other 382 (3%) 149 (2%)
Mechanical ventilation 0 91 (1%) 758 (12%) < 0.001
Mechanical circulatory support 0 < 0.001
  None 7,790 (59%) 4,778 (76%)
  Extracorporeal membrane oxygenation 31 (0.2%) 261 (4%)
  Ventricular assist device 5,378 (41%) 1,270 (20%)
Inotrope use 0 3,801 (29%) 4,183 (66%) < 0.001
Dialysis on waitlist 177 162 (1%) 214 (3%) < 0.001
Bilirubin > 2 mg/dL 344 985 (8%) 891 (14%) < 0.001
Infection requiring intravenous antibiotics 486 1,140 (9%) 1,106 (18%) < 0.001
Allograft ischemia time (h) 340 0.001
  < 2 1,533 (12%) 625 (10%)
  2 - 4 8,513 (66%) 4,102 (66%)
  > 4 2,932 (23%) 1,463 (24%)